A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Altamira Therapeutics Ltd’s current trading price is -95.56% away from its 52-week high, while its distance from the 52-week low is 197.87%. The stock’s price range for this time frame has been between $0.09 and $6.31. The trading volume of the company’s shares in the Healthcare reached around 323.53 million for the day, which was evidently higher than the average daily volume of 1.1 million over the last three months.
Currently, the stock price of Altamira Therapeutics Ltd (CYTO) is $0.28. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.478 after opening at $0.1555. The stock touched a low of $0.1501 before closing at $0.10.
Altamira Therapeutics Ltd’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $6.31 on 11/25/22, and the lowest price during the same period was recorded at $0.09 on 11/14/23.
How Financial Performance Impacts Market Capitalization
Altamira Therapeutics Ltd (CYTO) has experienced a quarterly decline of -22.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.47M and boasts a workforce of 18 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2971, with a change in price of -0.4394. Similarly, Altamira Therapeutics Ltd recorded 4,136,037 in trading volume during the last 100 days, posting a change of -61.08%.
CYTO Stock Stochastic Average
The raw stochastic average for Altamira Therapeutics Ltd over the last 50 days is presently at 48.44%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 48.44%. Further, the company’s Stochastic %K and %D values for the last 20 days were 19.18% and 9.10%, respectively.
CYTO Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -94.23%. However, over the past six months, we’ve seen a stronger performance of -68.36%. The price of CYTO fallen by 76.99% over the last 30 days. And in the last five days, it has surged by 162.91%.